UPCI Multiplexing Tissue Biomarker System grant success

The Cancer Immunotherapy Biomarkers supplement to the University of Pittsburgh Cancer Institute (UPCI) cancer center support grant from Dr. Lisa Butterfield, Professor of Medicine, Surgery, and Immunology, was successful, and will bring a multiplex tissue imaging system to UPCI, and initially test tumor infiltrate biomarkers in the phase III melanoma trial comparing CTLA-4 blockade vs Interferon in melanoma (A. Tarhini, ECOG 1609).